Physician profile
Michael Stephen Chevinsky
NPI 1205217122
$10,877.88
in general payments reported to CMS, 2019-2025
51 companies · $3,149 in 2025
The $3,149 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $41.76 · 2021: $762 · 2022: $2,647 · 2023: $1,150 · 2024: $2,766 · 2025: $3,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,867 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,866.88 |
| Education | $198.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $899.94 | 2022-2025 | Erleada, Carvykti, Rybrevant |
| Astellas Pharma US INC | $875.90 | 2019-2025 | Xtandi, Myrbetriq |
| Procept Biorobotics Corporation | $845.15 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Coloplast Corp | $728.50 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $626.29 | 2021-2025 | |
| Abbvie INC. | $524.51 | 2021-2025 | Lupron Depot, Botox |
| Teleflex LLC | $504.76 | 2022-2025 | Urolift, Barrigel |
| Antares Pharma, INC. | $496.65 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Sumitomo Pharma America, INC. | $475.02 | 2023-2025 | Orgovyx, Gemtesa |
| Olympus America INC. | $333.60 | 2022-2025 | Itind System |
| Ferring Pharmaceuticals INC. | $319.98 | 2024-2025 | Adstiladrin, Firmagon |
| C. R. Bard, INC. & Subsidiaries | $308.68 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $267.20 | 2024-2025 | Provenge |
| Intuitive Surgical, INC. | $265.36 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $245.62 | 2024-2025 | Jardiance |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $239.13 | 2021-2024 | Axonics, Bulkamid |
| Inari Medical, INC. | $203.75 | 2022 | |
| Urovant Sciences INC | $200.28 | 2022 | |
| Urogen Pharma, INC. | $191.40 | 2022-2025 | Jelmyto |
| Myriad Genetic Laboratories, INC. | $190.66 | 2022-2025 | Prolaris |
| Endo USA, INC. | $185.58 | 2024-2025 | Xiaflex, Aveed |
| Boston Scientific Corporation | $176.74 | 2019-2020 | |
| Abc Home Medical Supply, INC. | $176.49 | 2022-2025 | |
| Verity Pharmaceuticals INC. | $162.58 | 2021-2025 | Trelstar |
| Srs Medical Systems, INC. | $162.05 | 2024-2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Abbott Laboratories | $150.00 | 2024 | Freestyle Libre 3 |
| Myovant Sciences INC. | $122.28 | 2022 | |
| Tolmar, INC. | $99.60 | 2023-2025 | Jatenzo |
| Pfizer INC. | $96.25 | 2022-2025 | |
| Accord Healthcare, INC. | $78.13 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $60.49 | 2021-2023 | Xiaflex, Aveed |
| Immunitybio, INC. | $57.60 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $54.31 | 2023 | Seglentis |
| Biotissue Holdings INC. | $53.70 | 2021-2022 | |
| Telix Pharmaceuticals | $46.89 | 2023 | Illuccix |
| Novartis Pharmaceuticals Corporation | $46.76 | 2022-2025 | |
| Laborie Medical Technologies Corp. | $46.12 | 2023 | |
| Photocure INC | $38.24 | 2025 | Cysview |
| Hollister Incorporated | $36.37 | 2021-2022 | |
| Acerus Pharmaceuticals Corporation | $33.30 | 2021-2022 | |
| Medtronic, INC. | $31.55 | 2021 | |
| 180 Medical, INC. | $28.79 | 2023 | |
| Amgen INC. | $28.58 | 2021 | |
| Neotract INC. | $28.34 | 2019 | |
| Angiodynamics, INC. | $27.67 | 2023 | Nanoknife |
| Merck Sharp & Dohme LLC | $24.04 | 2025 | Welireg, Keytruda, Keytruda Qlex |
| Janssen Pharmaceuticals, INC | $20.88 | 2024 | Xarelto |
| Halozyme INC | $18.55 | 2023 | |
| Blue Earth Diagnostics | $15.75 | 2021 | |
| Sagent Pharmaceuticals | $14.22 | 2023 | Glydo |
| Becton, Dickinson and Company | $13.65 | 2023 | Bard Urinary Drainage Bag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Chevinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.